✦ LIBER ✦

New anticoagulants and thromboprophylaxis

✍ Scribed by Marnix R. Hoppener; Harry R. Büller

Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 69 KB
Volume: 92
Category: Article
ISSN: 0007-1323
DOI: 10.1002/bjs.4899

No coin nor oath required. For personal study only.

✦ Synopsis

May soon replace heparin and warfarin

📜 SIMILAR VOLUMES

Oral Anticoagulant Thromboprophylaxis fo

Oral Anticoagulant Thromboprophylaxis for Kawasaki Disease

✍ F. Newall; P. Monagle 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 52 KB

Anticoagulant therapy and thromboprophyl

Anticoagulant therapy and thromboprophylaxis in patients with thrombophilia

✍ Adi Y. Weintraub; Eyal Sheiner 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 202 KB

New oral anticoagulants

✍ Taki Galanis; Lynda Thomson; Michael Palladino; Geno J. Merli 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 206 KB

New anticoagulants and antiplatelet agen

New anticoagulants and antiplatelet agents

✍ Linda Shore-Lesserson 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 French ⚖ 71 KB

New Antithrombin-Based Anticoagulants

✍ Umesh R. Desai 📂 Article 📅 2004 🏛 John Wiley and Sons ⚖ 48 KB

New antithrombin-based anticoagulants

✍ Umesh R. Desai 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 705 KB

## Abstract Clinically used anticoagulants are inhibitors of enzymes involved in the coagulation pathway, primarily thrombin and factor Xa. These agents can be either direct or indirect inhibitors of clotting enzymes. Heparin‐based anticoagulants are indirect inhibitors that enhance the proteinase